Top Markets
#1 TENDIES TENDIES +37.02%
#2 Cash Cat Cash Cat +24.00%
#3 Asteroid Shiba Asteroid Shiba +16.86%
#4 OSK OSK +15.36%
#5 龙虾 (Lobster) 龙虾 (Lobster) +11.30%
#6 Bluwhale Bluwhale +10.73%
#7 MarsCoin MarsCoin +8.62%
#8 ROLL ROLL +7.54%
#9 CARV CARV +7.24%
#10 Pyth Network Pyth Network +7.13%
Coin of the day
TENDIES TENDIES
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Clasificación en acciones #16730
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Precio por acción
$3.78
Última sincronización: 2026-03-17
Capitalización bursátil
$276.54M
Cambio (1 día)
0.00%
Cambio (1 año)
45.53%
País
CA
Comercio NervGen Pharma Corp. (NGEN)

Categoría

Healthcare
Historial del precio de la acción de NervGen Pharma Corp. (NGEN)
Precio más alto de cierre: $3.98 el 2026-03-01

Precio más bajo de cierre: $1.12 el 2019-03-01
Historial del precio de la acción de NervGen Pharma Corp. desde 2019 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -18.31%
2025 129.35%
2024 42.00%
2023 15.06%
2022 -43.93%
2021 48.46%
2020 21.58%
2019 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.15 36.70%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.33%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $153.87 536.09%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.24 -10.01%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $748.60 6.90%
CH